Medication ComplianceNCT04713215
Thinking Outside the Box
An observational study of Medication Compliance and Medication Adherence, run by Guy's and St Thomas' NHS Foundation Trust at 1 site in United Kingdom.
Trial summary
Medication adherence - the extent to which a patient takes their medications as prescribed - is a global problem. Half of all medicines given to patients with long-term health problems are not taken properly by the patient. Read more about this study
- Who is it for?
- Ages 18 to 110 years
- Conditions the study is for
- Medication Compliance, Medication Adherence, Caregivers
- What is being tested?
- Questionnaire
- How many people
- 176 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 7 Jul 2021to 30 Jun 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 110 years
- All sexes
- Adult, Older adult
Study population: * Patients aged 65 or over currently using an MCA * Patients aged 65 or over previously offered an MCA but discontinued * Patients aged 65 or over previously offered an MCA but declined * Informal carers (aged 18 or over) of patients aged 65 or over, currently using an MCA * Informal carers (aged 18 or over) of patients aged 65 or over, who were previously offered an MCA but discontinued * Informal carers (aged 18 or over) of patients aged 65 or over, who were previously offered an MCA but declined
Patient inclusion criteria:
- Patients currently using an MCA or patients previously offered an MCA but declined or discontinued
- Age 65 years or older
- English speaker
- Sufficient cognitive function to complete questionnaire
Informal Carer inclusion criteria:
- A person who cares for someone aged 65 or older who is currently using a MCA or previously offered an MCA and declined or discontinued
- They assist the person they care for with their medication.
- Age 18 years or older
- English speaking
- Sufficient cognitive function to complete questionnaire
Patient exclusion criteria:
- Age less than 65 years
- Lacks capacity to consent to participate in study
- Deemed by the direct clinical care team to be too unwell to participate
- Declines participation
Informal carer exclusion criteria:
- Age less than 18 years
- Employed to assist patient
- Not involved with medication management
- Lacks capacity to consent to participate in study
- Declines participation
All participants must be able to speak English and have sufficient cognitive function to provide informed consent. Patients and carers will not all be recruited in pairs (i.e a patient and their carer). If a patient lacks capacity to give informed consent for inclusion in the study, they will not be approached for participation. Informal carers of these patients who meet the informal carer inclusion criteria will still be eligible to be approached.
Trial locations and contacts
1 site in 1 country.
United Kingdom1 site
Guy's and St Thomas' NHS Foundation Trust
London, SE1 7EH
About this study
Official title: Thinking Outside the Box: Exploring Patient and Carer Perceptions of Medication Compliance Aids (MCAs)
Medication adherence - the extent to which a patient takes their medications as prescribed - is a global problem. Half of all medicines given to patients with long-term health problems are not taken properly by the patient. Older adults are also more at risk of harm from their medications as they tend to take more medicines than young people, and are less able to cope with their effects.
There has been research into how to address these problems. One way has been through providing patients with a medication compliance aid (MCA), to help with taking their medications on time. MCAs are pre-packaged boxes containing tablets, grouped together according to the day and time the medication needs to be taken. Some patients buy the MCA and fill it themselves, other patients collect a MCA that their pharmacy makes for them.
Read more
There is not much proof that pharmacy-filled MCAs help patients, and some research suggests they may cause harm. The views of patients on MCA use have not yet been fully explored - it is not clear why some patients choose to stop using an MCA or refuse one when offered. Many patients with MCAs also have a family member or friend who helps them with their medication. No research has recognised the role of informal carers in helping patients with MCAs or asked them their thoughts.
This study aims to understand what patients, aged 65 and older, and their informal carers think about MCAs and how they affect their lives. It is a questionnaire study which will take place within a National Health Service (NHS) hospital. It's designed to take approximately 20 minutes, either face to face or by phone. The investigators hope that the results from this study will help to inform how healthcare professionals use MCAs to the benefit of patients and their carers.
Read the detailed description
Definitions Patient is defined as a service user in a hospital/outpatient/community setting, who may or may not have used an MCA in the past.
Informal Carer is a person who, in an unpaid capacity, supports a Patient in some aspect of their care - for the scope of this study, this must include assistance with medication. They will also be referred to as a Carer. It must be noted that paid carers are outside the scope of this study. A paid carer is someone in formal employment in a caring capacity.
Participant is defined as either a Patient or Informal Carer who consents to be part of the study, and have their data stored and used for the purposes outlined in this protocol.
Medication Compliance Aid(s), also referred to as Medication Aid(s) or MCAs, are pre-packaged boxes containing tablets correctly grouped together according to the day and time the medication needs to be taken, assembled by a pharmacist.
Research participants for this study will belong to the following 4 groups:
- Patients (inpatient or outpatient) aged 65 or over currently using an MCA
- Patients (inpatient or outpatient) aged 65 or over previously offered an MCA but declined/discontinued
- Informal carers (aged 18 or over) of patients (aged 65 or over) using MCAs.
- Informal carers (aged 18 or over) of patients (aged 65 or over) who were previously offered an MCA but it was declined/discontinued
All participants must be able to speak English and have sufficient cognitive function to provide informed consent.
Patients and informal carers will not be recruited in pairs (i.e patient and their informal carer). The investigators will be recruiting informal carers of patients that have cognitive impairment and some of the patients with cognitive impairment will not have sufficient capacity to partake in the survey themselves. However, their informal carers are an important and large group of those supporting patients with their medications and therefore need to be included in this study.
Setting:
Data collection for this single-centre study will be taken from participants identified through various means including outpatient attendees (telephone and face to face), inpatient wards and community settings e.g. a hospital @home team. The hospital @home team involves a "community ward", involving doctors, nurses, pharmacists and therapy teams employed by the same NHS Foundation Trust, where clinicians assess and treat patients in their homes.
Informal carers who assist with medications are identified in these settings as part of normal clinical practice on hospital admission, clinic or @home review and also in discharge planning activities.
The investigators will also place posters in an outpatient clinic waiting room within the older persons assessment unit, to advertise the study to patients and informal carers.
Identification of participants:
Potential participants will be approached and screened by their clinical care team during the course of routine clinical activity. A member of the direct clinical team will approach potential participants, confirm eligibility using a standardised set of screening questions, describe the study briefly and ask for verbal consent for their name and phone number to be passed to the research team. Informal carers are commonly identified by clinical teams as part of routine admission questions when a patient is admitted to hospital, as formal (paid) care arrangements need to be distinguished from informal arrangements for the purpose of discharge assessment and onward care at home. Identification of who assists with the patient's medications is also identified as part of routine care by pharmacy staff. The investigators will encourage members of the direct clinical care team to ask informal carers the screening questions during routine care discussions and whether they would be interested in taking part. If yes, the clinical team member will pass on their contact details.
If a patient lacks capacity to give informed consent for inclusion in the study, they will not be approached for participation. Informal carers of these patients who meet the informal carer inclusion criteria will still be eligible to be approached and will be contacted by the clinical team looking after the patient in the first instance to check eligibility and inquire regarding whether they are interested in taking part. This contact will be during a routine clinical activity such as obtaining a collateral history from an informal carer.
Recruitment: On approach by researcher, participants will be given a description of the study verbally (face to face or via phone). All potential participants will be given a copy of the written participant information sheet prior to completing the questionnaire.
Verbal consent to proceed with the questionnaire will be sought. Optional consent will also be sought to record a participant's email or postal address to disseminate a lay summary of results on completion of the study.
Questionnaire:
Participants will complete a short questionnaire containing a mix of quantitative and qualitative questions with scope to include free-text comments.
The questions will vary according to whether the participant is a patient or carer, and whether they are currently using a pharmacy-filled MCA, previously discontinued a pharmacy-filled MCA or have previously declined a pharmacy-filled MCA. The questions will explore the following;
For patients, and the informal carers of patients, who use MCAs
- Establish patient and informal carer opinions of MCAs
- Determine whether those who use MCAs would consider switching to taking medicines in their original packaging
For patients, and the informal carers of patients, who have used an MCA in the past but no longer do so
- Establish patient and informal carer opinions of an MCA
- Explore patient and informal carers reasons for stopping an MCA
- Explore alternative ways in which patients and informal carers organise medications without the use of an MCA
For patients and their informal carers who have been offered an MCA but declined
- Explore why the MCA was declined
- Explore alternative ways in which patients and their informal carers organise medications without the use of an MCA
- To explore what further support they would like to help them adhere to their medications
The researchers will administer the questionnaire in all settings including face to face and phone call. This will broaden participation to those who have difficulty reading and writing.
Close of interaction:
The participant will be thanked for their time and any further questions will be answered. No further interactions will occur.
- Conditions
- Medication Compliance, Medication Adherence, Caregivers, Attitude
- Being tested
- Questionnaire
- Keywords
- Medication Compliance, Medication Adherence, Caregivers, Attitude
- Medical subject headings
- Medication Adherence, Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
QuestionnaireOther
A short (approximately 20-minute) questionnaire will be administered to patients and carers who meet the inclusion criteria and who have expressed and interested, and consented to completing the questionnaire.
| Study group | Role | What they receive |
|---|---|---|
| Patients where MCAs are currently being used | Intervention: Patient questionnaire - Part A - patients where MCAs are currently being used Receives: Other: Questionnaire | |
| Patients where an MCA was discontinued | Intervention: Patient questionnaire - Part B - patients where an MCA was discontinued Receives: Other: Questionnaire | |
| Patients where an MCA was declined | Intervention: Patient questionnaire - Part C - patients where an MCA was declined Receives: Other: Questionnaire | |
| Carers where MCAs are currently being used | Intervention: Carer questionnaire - Part A - carers where MCAs are currently being used Receives: Other: Questionnaire | |
| Carers where an MCA was discontinued | Intervention: Carer questionnaire - Part B - carers where an MCA was discontinued Receives: Other: Questionnaire | |
| Carers where an MCA was declined | Intervention: Carer questionnaire - Part C - carers where an MCA was declined Receives: Other: Questionnaire |
What is being measured
The primary outcome is the main question the study is designed to answer.
To determine patients' and carers' opinions of medication compliance aids
Through qualitative and quantitative analysis
Measured: 12 months
Secondary outcomes (1)
To determine whether those using MCAs would consider reverting to medicines in original packaging and what they might require to support this change.
Through qualitative and quantitative analysis
Measured: 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Jan 2021
- Study start7 Jul 2021
- Primary completion30 Jun 2022
- Study completion30 Jun 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Medication ComplianceStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Retrospective
- Enrolment
- 176 participants (actual)
Sponsor and investigators
- Lead sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Sponsor type
- University, hospital or other
- Collaborators
- King's College London, Sir Halley Stewart Trust
- Responsible party
- Sponsor
- Investigators
- Rebekah Schiff, BSc, MBBS, Principal investigator, Guy's and St Thomas' NHS Foundation Trust
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04713215
- Sponsor's protocol ID
- 289976
- Other IDs
- 2782
- Status last verified
- Jul 2021
- First submitted
- 14 Jan 2021
- Last updated
- 2 Feb 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Thielemans L, Chin K, Hegarty A, Schiff R. Carer involvement in medication adherence: carer views and experiences of facilitating medication adherence using pharmacy-filled multi-compartment medication compliance aids and other methods of adherence support-a questionnaire survey. Age Ageing. 2023 Oct 2;52(10):afad169. doi: 10.1093/ageing/afad169.
PubMed 37930740
Study at a glance
From the registry record, last updated by the sponsor on 2 Feb 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Thinking Outside the Box: Exploring Patient and Carer Perceptions of Medication Compliance Aids (MCAs)
- ClinicalTrials.gov ID
- NCT04713215
- Acronym / sponsor ID
- 289976
- Conditions
- Medication Compliance, Medication Adherence, Caregivers, Attitude
- Keywords
- Medication Compliance, Medication Adherence, Caregivers, Attitude
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 176 participants (actual)
- Lead sponsor
- Guy's and St Thomas' NHS Foundation TrustUniversity, hospital or other
- Collaborators
- King's College London, Sir Halley Stewart Trust
- Study start
- 7 Jul 2021 (actual)
- Primary completion
- 30 Jun 2022 (actual)
- Study completion
- 30 Jun 2022 (actual)
- First posted
- 19 Jan 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Medication adherence - the extent to which a patient takes their medications as prescribed - is a global problem. Half of all medicines given to patients with long-term health problems are not taken properly by the patient. Older adults are also more at risk of harm from their medications as they tend to take more medicines than young people, and are less able to cope with their effects.
There has been research into how to address these problems. One way has been through providing patients with a medication compliance aid (MCA), to help with taking their medications on time. MCAs are pre-packaged boxes containing tablets, grouped together according to the day and time the medication needs to be taken. Some patients buy the MCA and fill it themselves, other patients collect a MCA that their pharmacy makes for them.
There is not much proof that pharmacy-filled MCAs help patients, and some research suggests they may cause harm. The views of patients on MCA use have not yet been fully explored - it is not clear why some patients choose to stop using an MCA or refuse one when offered. Many patients with MCAs also have a family member or friend who helps them with their medication. No research has recognised the role of informal carers in helping patients with MCAs or asked them their thoughts.
This study aims to understand what patients, aged 65 and older, and their informal carers think about MCAs and how they affect their lives. It is a questionnaire study which will take place within a National Health Service (NHS) hospital. It's designed to take approximately 20 minutes, either face to face or by phone. The investigators hope that the results from this study will help to inform how healthcare professionals use MCAs to the benefit of patients and their carers.
Detailed description
Definitions Patient is defined as a service user in a hospital/outpatient/community setting, who may or may not have used an MCA in the past.
Informal Carer is a person who, in an unpaid capacity, supports a Patient in some aspect of their care - for the scope of this study, this must include assistance with medication. They will also be referred to as a Carer. It must be noted that paid carers are outside the scope of this study. A paid carer is someone in formal employment in a caring capacity.
Participant is defined as either a Patient or Informal Carer who consents to be part of the study, and have their data stored and used for the purposes outlined in this protocol.
Medication Compliance Aid(s), also referred to as Medication Aid(s) or MCAs, are pre-packaged boxes containing tablets correctly grouped together according to the day and time the medication needs to be taken, assembled by a pharmacist.
Research participants for this study will belong to the following 4 groups:
- Patients (inpatient or outpatient) aged 65 or over currently using an MCA
- Patients (inpatient or outpatient) aged 65 or over previously offered an MCA but declined/discontinued
- Informal carers (aged 18 or over) of patients (aged 65 or over) using MCAs.
- Informal carers (aged 18 or over) of patients (aged 65 or over) who were previously offered an MCA but it was declined/discontinued
All participants must be able to speak English and have sufficient cognitive function to provide informed consent.
Patients and informal carers will not be recruited in pairs (i.e patient and their informal carer). The investigators will be recruiting informal carers of patients that have cognitive impairment and some of the patients with cognitive impairment will not have sufficient capacity to partake in the survey themselves. However, their informal carers are an important and large group of those supporting patients with their medications and therefore need to be included in this study.
Setting:
Data collection for this single-centre study will be taken from participants identified through various means including outpatient attendees (telephone and face to face), inpatient wards and community settings e.g. a hospital @home team. The hospital @home team involves a "community ward", involving doctors, nurses, pharmacists and therapy teams employed by the same NHS Foundation Trust, where clinicians assess and treat patients in their homes.
Informal carers who assist with medications are identified in these settings as part of normal clinical practice on hospital admission, clinic or @home review and also in discharge planning activities.
The investigators will also place posters in an outpatient clinic waiting room within the older persons assessment unit, to advertise the study to patients and informal carers.
Identification of participants:
Potential participants will be approached and screened by their clinical care team during the course of routine clinical activity. A member of the direct clinical team will approach potential participants, confirm eligibility using a standardised set of screening questions, describe the study briefly and ask for verbal consent for their name and phone number to be passed to the research team. Informal carers are commonly identified by clinical teams as part of routine admission questions when a patient is admitted to hospital, as formal (paid) care arrangements need to be distinguished from informal arrangements for the purpose of discharge assessment and onward care at home. Identification of who assists with the patient's medications is also identified as part of routine care by pharmacy staff. The investigators will encourage members of the direct clinical care team to ask informal carers the screening questions during routine care discussions and whether they would be interested in taking part. If yes, the clinical team member will pass on their contact details.
If a patient lacks capacity to give informed consent for inclusion in the study, they will not be approached for participation. Informal carers of these patients who meet the informal carer inclusion criteria will still be eligible to be approached and will be contacted by the clinical team looking after the patient in the first instance to check eligibility and inquire regarding whether they are interested in taking part. This contact will be during a routine clinical activity such as obtaining a collateral history from an informal carer.
Recruitment: On approach by researcher, participants will be given a description of the study verbally (face to face or via phone). All potential participants will be given a copy of the written participant information sheet prior to completing the questionnaire.
Verbal consent to proceed with the questionnaire will be sought. Optional consent will also be sought to record a participant's email or postal address to disseminate a lay summary of results on completion of the study.
Questionnaire:
Participants will complete a short questionnaire containing a mix of quantitative and qualitative questions with scope to include free-text comments.
The questions will vary according to whether the participant is a patient or carer, and whether they are currently using a pharmacy-filled MCA, previously discontinued a pharmacy-filled MCA or have previously declined a pharmacy-filled MCA. The questions will explore the following;
For patients, and the informal carers of patients, who use MCAs
- Establish patient and informal carer opinions of MCAs
- Determine whether those who use MCAs would consider switching to taking medicines in their original packaging
For patients, and the informal carers of patients, who have used an MCA in the past but no longer do so
- Establish patient and informal carer opinions of an MCA
- Explore patient and informal carers reasons for stopping an MCA
- Explore alternative ways in which patients and informal carers organise medications without the use of an MCA
For patients and their informal carers who have been offered an MCA but declined
- Explore why the MCA was declined
- Explore alternative ways in which patients and their informal carers organise medications without the use of an MCA
- To explore what further support they would like to help them adhere to their medications
The researchers will administer the questionnaire in all settings including face to face and phone call. This will broaden participation to those who have difficulty reading and writing.
Close of interaction:
The participant will be thanked for their time and any further questions will be answered. No further interactions will occur.
Study design
- Observational model
- Case only
- Time perspective
- Retrospective
- Number of arms
- 6
| Arm | Type | Receives |
|---|---|---|
| Patients where MCAs are currently being used | – | Other: QuestionnaireIntervention: Patient questionnaire - Part A - patients where MCAs are currently being used |
| Patients where an MCA was discontinued | – | Other: QuestionnaireIntervention: Patient questionnaire - Part B - patients where an MCA was discontinued |
| Patients where an MCA was declined | – | Other: QuestionnaireIntervention: Patient questionnaire - Part C - patients where an MCA was declined |
| Carers where MCAs are currently being used | – | Other: QuestionnaireIntervention: Carer questionnaire - Part A - carers where MCAs are currently being used |
| Carers where an MCA was discontinued | – | Other: QuestionnaireIntervention: Carer questionnaire - Part B - carers where an MCA was discontinued |
| Carers where an MCA was declined | – | Other: QuestionnaireIntervention: Carer questionnaire - Part C - carers where an MCA was declined |
Who may qualify
- Ages
- 18 to 110 years
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- * Patients aged 65 or over currently using an MCA * Patients aged 65 or over previously offered an MCA but discontinued * Patients aged 65 or over previously offered an MCA but declined * Informal carers (aged 18 or over) of patients aged 65 or over, currently using an MCA * Informal carers (aged 18 or over) of patients aged 65 or over, who were previously offered an MCA but discontinued * Informal carers (aged 18 or over) of patients aged 65 or over, who were previously offered an MCA but declined
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| QuestionnaireA short (approximately 20-minute) questionnaire will be administered to patients and carers who meet the inclusion criteria and who have expressed and interested, and consented to completing the questionnaire. | Other | Carers where MCAs are currently being used, Carers where an MCA was declined, Carers where an MCA was discontinued, Patients where MCAs are currently being used, Patients where an MCA was declined, Patients where an MCA was discontinued |
Primary outcome
To determine patients' and carers' opinions of medication compliance aids
Time frame: 12 months
Through qualitative and quantitative analysis
1 secondary outcome
To determine whether those using MCAs would consider reverting to medicines in original packaging and what they might require to support this change.
Time frame: 12 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Feb 2024.
- Results publication: PubMed 37930740Thielemans L, Chin K, Hegarty A, Schiff R. Carer involvement in medication adherence: carer views and experiences of facilitating medication adherence using pharmacy-filled multi-compartment medication compliance aids and other methods of adherence support-a questionnaire survey. Age Ageing. 2023 Oct 2;52(10):afad169. doi: 10.1093/ageing/afad169.
- Individual participant dataSharing planned: No
Related trials for Medication Compliance
Not yet recruitingObservational study
Daily Cognitive Failures and Medication Adherence in Fibromyalgia
Fibromyalgia
Active, not recruiting
A Mobile App to Improve 24-Hour Movement Guideline Adherence in Preschoolers
Healthy, 24-Hour Movement Guidelines
RecruitingPhase 4
Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
Cataract, Surgery
Not yet recruitingObservational study
Factors Influencing Adoption of a Novel Malaria Treatment in Côte d'Ivoire, Ghana, and Rwanda
Malaria
Enrolling by invitationObservational study
Heart Rate Variability and Medication Adherence in Resistant Hypertension
Resistant Hypertension, Medication Adherence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Rebekah Schiff, BSc, MBBS principal investigator
Guy's and St Thomas' NHS Foundation Trust
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Medication Compliance and Medication Adherence, run by Guy's and St Thomas' NHS Foundation Trust at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
To determine patients' and carers' opinions of medication compliance aids (time frame: 12 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04713215, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Feb 2024.